Skip to content
FDA drug shortage status

Is Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops (Cipro Hc) in shortage?

Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops is listed by FDA as being discontinued by at least one maker (updated Oct 30, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)
    Sandoz Inc.Being discontinuedUpdated Oct 30, 2026Discontinued Oct 30, 2026

    Discontinuation of the manufacturing of NDC 66758-087-70. Authorized generic is available under new NDC 0781-6218-70

    Maker contact: 800-525-8747

FDA recalls of the same active ingredient

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops:

Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops shortage questions

Is Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops (Cipro Hc) in shortage?

Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops is listed by FDA as being discontinued by at least one maker (updated Oct 30, 2026).

What should I do if I can’t get Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.